Meet the Members of the ACI’s Biosimilars Advisory Board:
Mark Bowditch Vice President, Intellectual Property and Litigation Coherus Biosciences, Inc.
Thomas Felix, M.D. Medical Director, R&D Policy Global Regulatory Affairs and Safety Amgen
Reza Green Vice President, Intellectual Property Novo Nordisk
Lutz Hilbrich, M.D., M.B.A. Vice President, Head Biosimilars Platform China Sanofi
Bruce A. Leicher Senior Vice President and General Counsel Momenta Pharmaceuticals
Jennifer Zarutskie Sieczkiewicz, Ph.D., J.D. Research and Business Development Counsel Biogen Inc.
Immac (“Casey”) Thampoe, Ph.D., J.D. Assistant General Counsel – IP Portfolio Development Regeneron Pharmaceuticals Inc.